Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex

Pharmacological Reports

Volumn 61, Issue 4, 2009, Pages 612-620

  Szymańska, Magdalena ^a   Suska, Anna ^a   Budziszewska, Bogusława ^a,b   Jaworska Feil, Lucylla ^a   Basta Kaim, Agnieszka ^a   Leśkiewicz, Monika ^a   Kubera, Marta ^a   Gergont, Aleksandra ^b   Kroczka, Sławomir ^b   Kaciński, Marek ^b   Lasoń, Władysław ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Antidepressant drugs; Depression; Glycogen synthase kinase 3 ; Prenatal stress; Protein kinase B

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; IMIPRAMINE; MIRTAZAPINE; PROTEIN KINASE B; TIANEPTINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; HYPERACTIVITY; IMMOBILIZATION; LONG TERM CARE; MALE; NONHUMAN; PRENATAL STRESS; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 70549096117     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70113-6     Document Type: Article

References (44)

1. Bachis A, Cruz MI, Nosheny RL, Mocchetti I: Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci Lett, 2008, 442, 104-108.
2. Barbazanges A, Piazza PV, Le Moal M, Maccari S: Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci, 1996, 16, 3943-3949. (Pubitemid 26176058)
3. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM., Sousa N: The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci, 2007, 27, 2781-2787. (Pubitemid 46438976)
4. Chiu K, Lau WM, Lau HT, So KF, Chang RC: Microdissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp, 2007, 7, 269.
5. Drevets WC: Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res, 2000, 126, 413-431.
6. D'sa C, Duman RS: Antidepressants and neuroplasticity. Bipolar Disord, 2002, 4, 183-194.
7. Duman RS, Malberg J, Thome J: Neural plasticity to stress and antidepressant treatment. Biol Psychiatry, 1999, 46, 1181-1191. (Pubitemid 30114436)
8. Feng P, Guan Z, Yang X, Fang J: Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res, 2003, 991, 195-205. (Pubitemid 37297949)
9. Fujioka A, Fujioka T, Ishida Y, Maekawa T, Nakamura S: Differential effects of prenatal stress on the morphological maturation of hippocampal neurons. Neuroscience, 2006, 141, 907-915. (Pubitemid 44066657)
10. Gould TD, Einat H, Bhat R, Manji HK: AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol, 2004, 7, 387-390. (Pubitemid 39648068)
11. Jope RS, Roh MS: Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets, 2006, 7, 1421-1434.
12. Koehl M, Darnaudery M, Dulluc J, Van Reeth O, Le Moal M, Maccari S: Prenatal stress alters circadian activity of hypothalamo-pitaitary-adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender. J Neurobiol, 1999, 40, 302-315. (Pubitemid 29382857)
13. Lau KF, Miller CC, Anderton BH, Shaw PC: Molecular cloning and characterization of the human glycogen synthase kinase-3β promoter. Genomics, 1999, 60, 121-128. (Pubitemid 29463670)
14. Lemaire V, Koehl M, Le Moal M, Abrous DN: Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA, 2000, 97, 11032-11037.
15. Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS: In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain. Neuropsychopharmacology, 2004, 29, 1426-1431.
16. Linkowski P, Mendlewicz J, LeClerc R, Brasseur M, Hubain P, Goldstein J, Copinschi G, Van Cauter E: The 24-hour profile of ACTH and cortisol in major depressive illness. J Clin Endocrinol Metab, 1985, 61, 429-438.
17. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 1951, 193, 265-275.
18. Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nat Med, 2001, 7, 541-547.
19. Matthews SG: Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res, 2000, 47, 291-300.
20. Morley-Fletcher S, Darnaudery M, Koehl M, Casolini P, Van Reeth O, Maccari S: Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res, 2003, 989, 246-251.
21. 1A receptor mRNA in prenatally stressed rats. Neuropharmacology, 2004, 47, 841-847. (Pubitemid 39440978)
22. Nemeroff C B, Widerlov E, Bisette G, Walleus H, Karlsson I, Eklund K, Kilts CD et al.: Elevated concentrations of CSF corticotropin releasing factor-like immunoreactivity in depressed patients. Science, 1984, 226, 1342-1344.
23. Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL: The role of GSK-3 in synaptic plasticity. Br J Pharmacol, 2008, 153, S428-S437.
24. Pittenger C, Duman RS: Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology, 2008, 33, 88-109. (Pubitemid 350191319)
25. Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, Peng SL et al.: Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry, 2009, 65, 150-159.
26. Porsolt RD, Anton G, Blavet N, Jalfre M: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol, 1978, 47, 379-391.
27. Radley JJ, Morrison JH: Repeated stress and structural plasticity in the brain. Ageing Res Rev, 2005, 4, 271-287. (Pubitemid 41111982)
28. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC et al.: Morphometry evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry, 1999, 45, 1085-1098.
29. Rao U, McGinty DJ, Shinde A, McCracken JT, Poland RE: Prenatal stress is associated with depression-related electroencephalographic sleep changes in adult male rats: a preliminary report. Prog Neuropsychopharmacol Biol Psychiatry, 1999, 23, 929-939. (Pubitemid 29416765)
30. Rhees R.W, Al-Saleh HN, Kinghorn EW, Fleming DE, Lephart ED: Relationship between sexual behavior and sexually dimorphic structures in the anterior hypothalamus in control and prenatally stressed male rats. Brain Res Bull, 1999, 50, 193-199.
31. 1-adrenergic systems in rats. Pharmacol Rep, 2007, 59, 588-594.
32. Roh MS, Eom TY, Zmijewska AA, De Sarno P, Roth KA, Jope RS: Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol Psychiatry, 2005, 57, 278-286. (Pubitemid 40187372)
33. Rosa AO, Kaster MP, Binfaré RW, Morales S, Martin-Aparicio E, Navarro-Rico ML, Martinez A et al.: Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32, 1549-1556.
34. Sairanen M, O'Leary OF, Knuuttila JE, Castrén E: Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience, 2007, 144, 368-374. (Pubitemid 44839045)
35. Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry, 2000, 57, 925-935.
36. Schakman O, Kalista S, Bertrand L, Lause P, Verniers J, Ketelslegers JM, Thissen JP: Role of Akt/GSK-3β/β-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats. Endocrinology, 2008, 149, 3900-3908.
37. Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leǎo P, Almeida OF, Sousa N: Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase- 3β. Neuroscience, 2008, 152, 656-669.
38. Skórzewska A, Bidziński A, Hamed A, Lehner M, Turzyńska D, Sobolewska A, Walkowiak J, Plaźnik A: Changes in hippocampal amino acid concentrations after chronic administration of corticosterone. Pharmacol Rep, 2007, 59, 763-772. (Pubitemid 351586570)
39. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci, 1995, 15, 1768-1777.
40. Sotiropoulos I, Catania C, Riedemann T, Fry JP, Breen KC, Michaelidis TM, Almeida OF: Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J Neurochem, 2008, 107, 385-397.
41. Szymańska M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Kubera M, Leśkiewicz M, Regulska M, Lasoń W: The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology, 2009, 34, 822-832.
42. Vallée M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S: Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci, 1997, 17, 2626-2636. (Pubitemid 27137428)
43. Van den Bergh BR, Van Calster B, Smits T, Van Huffel S, Lagae L: Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology, 2008, 33, 536-545.
44. Wang X, Hu J, Price SR: Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells. Am J Physiol Cell Physiol, 2007, 292, C1874-C1879.